{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T23:13:59Z","timestamp":1771542839323,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":3148,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.jpainsymman.2010.08.017","type":"journal-article","created":{"date-parts":[[2011,3,13]],"date-time":"2011-03-13T04:23:06Z","timestamp":1299990186000},"page":"1098-1105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["A Strategy for Conversion From Subcutaneous to Oral Ketamine in Cancer Pain Patients: Effect of a 1:1 Ratio"],"prefix":"10.1016","volume":"41","author":[{"given":"Miguel Angel","family":"Ben\u00edtez-Rosario","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Salinas-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toribio","family":"Gonz\u00e1lez-Guillermo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Feria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2010.08.017_bib1","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1856::AID-CNCR30>3.0.CO;2-G","article-title":"Opioid rotation for cancer pain: rationale and clinical aspects","volume":"86","author":"Mercadante","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib2","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1097\/AJP.0b013e31816b5976","article-title":"Adjuvant agents in cancer pain","volume":"24","author":"McGeeney","year":"2008","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib3","article-title":"The essential adjuvant analgesics for neuropathic pain","volume":"15","author":"Colleau","year":"2002","journal-title":"Cancer Pain Release"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib4","author":"Quibell"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.36076\/ppj.2007\/10\/493","article-title":"Ketamine: an introduction for the pain and palliative medicine physician","volume":"10","author":"Okon","year":"2007","journal-title":"Pain Physician"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib6","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0885-3924(03)00072-1","article-title":"A retrospective comparison of the dose ratio between subcutaneous and oral ketamine","volume":"25","author":"Ben\u00edtez-Rosario","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jpainsymman.2004.04.005","article-title":"Subanesthetic ketamine: an essential adjuvant for intractable pain","volume":"28","author":"Kotlinska-Lemieszek","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/jpm.2005.8.49","article-title":"Parenteral ketamine as an analgesic adjuvant for severe pain: development and retrospective audit of a protocol for a palliative care unit","volume":"8","author":"Fitzgibbon","year":"2005","journal-title":"J Palliat Med"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0885-3924(00)00194-9","article-title":"Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study","volume":"20","author":"Mercadante","year":"2000","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/109662103322144808","article-title":"Ketamine to control pain","volume":"6","author":"Prommer","year":"2003","journal-title":"J Palliat Med"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0885-3924(98)00144-4","article-title":"Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain","volume":"17","author":"Fine","year":"1999","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib12","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0885-3924(01)00340-2","article-title":"Burst ketamine for refractory cancer pain. An open label audit of 39 patients","volume":"22","author":"Jackson","year":"2001","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0885-3924(01)00373-6","article-title":"Oral ketamine as an adjuvant to oral morphine for neuropathic pain in cancer patients","volume":"23","author":"Kannan","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib14","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1097\/00000542-199906000-00005","article-title":"Oral ketamine and transdermal nitroglycerine as analgesic adjuvants to oral morphine therapy for cancer pain management","volume":"90","author":"Lauretti","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1445-5994.2004.00727.x","article-title":"Prospective audit of short-term concurrent ketamine, opioid and anti-inflammatory (\u2018triple-agent\u2019) therapy for episodes of acute on chronic pain","volume":"35","author":"Good","year":"2005","journal-title":"Intern Med J"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1526-4637.2006.00208_8.x","article-title":"Bioavailability of ketamine after oral or sublingual administration","volume":"7","author":"Chong","year":"2006","journal-title":"Pain Med"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib17","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/bja\/53.8.805","article-title":"Pharmacokinetics and analgesic effects of i.m. and oral ketamine","volume":"53","author":"Grant","year":"1981","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0378-4347(00)00331-5","article-title":"Stereoselective high-performance liquid chromatographic determination of ketamine and its active metabolite, norketamine, in human plasma","volume":"746","author":"Yanagihara","year":"2000","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-2999(97)01116-3","article-title":"Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord","volume":"333","author":"Ebert","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0885-3924(00)00213-X","article-title":"Targeting the N-methyl-D-aspartate receptor for chronic pain management: preclinical animal studies, recent clinical experience and future research directions","volume":"20","author":"Fisher","year":"2000","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3959(98)00269-3","article-title":"Oral ketamine is antinociceptive in the rat formalin test: role of the metabolite, norketamine","volume":"81","author":"Shimoyama","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib22","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.pbb.2008.05.011","article-title":"Effects of norketamine enantiomers in rodent models of persistent pain","volume":"90","author":"Holtman","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib23","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1213\/01.ANE.0000086618.28845.9B","article-title":"Ketamine in chronic pain management: an evidence-based review","volume":"97","author":"Hocking","year":"2003","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib24","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0022-3565(24)38236-9","article-title":"Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain","volume":"289","author":"Raben","year":"1999","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib25","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ejpain.2009.09.005","article-title":"Use of oral ketamine in chronic pain management: a review","volume":"14","author":"Blonk","year":"2010","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pain.2009.05.021","article-title":"Ketamine and chronic pain\u2014going the distance","volume":"145","author":"Borsook","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib27","article-title":"Population pharmacokinetic-pharmacodynamic modeling of ketamine-induced pain relief of chronic pain","author":"Dahan","year":"2010","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0304-3959(99)00044-5","article-title":"Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes","volume":"82","author":"Schmid","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib29","first-page":"287","article-title":"Ketamine in the treatment of refractory cancer pain: case report, rationale and methodology","volume":"1","author":"Slatkin","year":"2003","journal-title":"J Support Oncol"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib30","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0885-3924(99)00011-1","article-title":"Clinical experience with oral ketamine","volume":"17","author":"Enarson","year":"1999","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1399-6576.1997.tb04710.x","article-title":"Oral ketamine therapy in the treatment of postamputation stump pain","volume":"41","author":"Nikolajsen","year":"1997","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib32","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/BF03017431","article-title":"Short- and long-term efficacy of oral ketamine in eight chronic-pain patients","volume":"49","author":"Furuhashi-Yonaha","year":"2002","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0885-3924(99)00018-4","article-title":"Analgesic effect of oral ketamine in chronic neuropathic pain of spinal origin: a case report","volume":"18","author":"Fisher","year":"1999","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib34","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0304-3959(99)00117-7","article-title":"N of 1 randomised controlled trials of oral ketamine in patients with chronic pain","volume":"83","author":"Haines","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1526-4637.2007.00314.x","article-title":"Side effects of ketamine in the long-term treatment of neuropathic pain","volume":"9","author":"Cvrcek","year":"2008","journal-title":"Pain Med"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib36","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.urology.2007.01.038","article-title":"Ketamine-associated ulcerative cystitis: a new clinical entity","volume":"69","author":"Shahani","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib37","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/j.1464-410X.2008.07920.x","article-title":"The destruction of the lower urinary tract by ketamine abuse: a new syndrome?","volume":"102","author":"Chu","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.jpainsymman.2010.08.017_bib38","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1177\/0269216309106828","article-title":"Can ketamine prescribed for pain cause damage to the urinary tract?","volume":"23","author":"Storr","year":"2009","journal-title":"Palliat Med"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392411000157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392411000157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:06:22Z","timestamp":1760130382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392411000157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0885392411000157"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2010.08.017","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Strategy for Conversion From Subcutaneous to Oral Ketamine in Cancer Pain Patients: Effect of a 1:1 Ratio","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2010.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}